Loading data for CELU — first visit, this takes a few seconds.
Celularity Inc. (CELU)
NasdaqCM: CELU
· Real-Time Price · USD
1.58
-0.52 (-24.76%)
At close: Sep 02, 2026, 7:16 PM
The price, the headline numbers and the latest news, in one place.
Celularity Inc. (CELU) Stock Price, Analysis & Data
No data available
| Bid | 1.2 |
| Market Cap | 52.4M |
| Revenue (ttm) | 26.6M |
| Net Income (ttm) | -91.8M |
| 0.54 | |
| -3.59 | |
| n/a | |
| -3.18 | |
| P/B (ttm) | -1.37 |
| P/S (ttm) | 1.97 |
| Earnings Date | Aug 18, 2025 |
| Ask | 1.62 |
| Volume | 15,014,392 |
| Avg. Volume (20D) | 3,859,276 |
| Open | 2.16 |
| Previous Close | 2.10 |
| Day's Range | 1.48 - 2.20 |
| 52-Week Range | 0.56 - 3.15 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CELU
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. Its therapeutic programs include PDA-001...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 8, 2019
Employees 115
Stock Exchange NasdaqCM
Ticker Symbol CELU
Website https://www.celularity.com
Financial Performance
In 2025, Celularity's revenue was 26.55M, a decrease of -51.03% compared to the previous year's 54.22M. Earnings were -91.72M, an increase of 58.43%.
Financial StatementsEarnings Surprise
Celularity has released their quarterly earnings on Aug 14, 2023:
- Revenue of $4.1M misses estimates by $0, with -77.37% YoY decline.
- EPS of -2.7 misses estimates by -2.40, with -184.38% YoY decline.
Celularity Inc. is scheduled to release its earnings on Aug 18, 2025, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade